AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis

Nature Medicine

Volumn 11, Issue 12, 2005, Pages 1290-1292

  Gao, Xiaojiang ^a   Bashirova, Arman ^b   Iversen, Astrid K N ^c   Phair, John ^d   Goedert, James J ^e   Buchbinder, Susan ^f   Hoots, Keith ^g   Vlahov, David ^h   Altfeld, Marcus ⁱ   O'Brien, Stephen J ^j   Carrington, Mary ^a  

^a SAIC FREDERICK INC   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NORTHWESTERN UNIVERSITY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h NEW YORK ACADEMY OF MEDICINE   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; HLA B57 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ALLOTYPE; ARTICLE; CELLULAR IMMUNITY; CHRONIC DISEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS VIRULENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALLELES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; HIV-1; HLA-B ANTIGENS; HUMANS; SURVIVAL ANALYSIS; TIME FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 28644451011     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1333     Document Type: Article

References (15)

1. Carrington, M. & O'Brien, S.J. Annu. Rev. Med. 54, 535-551 (2003).
2. Goulder, P.J. et al. Nat. Med. 3, 212-217 (1997).
3. Nixon, D.F. et al. Nature 336, 484-487 (1988).
4. Kelleher, A.D. et al. J. Exp. Med. 193, 375-386 (2001).
5. Feeney, M.E. et al. J. Virol. 78, 8927-8930 (2004).
6. Altfeld, M. et al. AIDS 17, 2581-2591 (2003).
7. Leslie, A.J. et al. Nat. Med. 10, 282-289 (2004).
8. Goulder, P.J. et al. Nature 412, 334-338 (2001).
9. Pillay, T. et al. J. Virol. 79, 12100-12105 (2005).
10. Jin, X. et al. J. Virol. 76, 12603-12610 (2002).
11. Morb. Mortal. Wkly. Rep. 41, 1-19 (1992).
12. Morb. Mortal. Wkly. Rep. 36, 3S-15S (1987).
13. Goulder, P.J. & Watkins, D.I. Nat. Rev. Immunol. 4, 630-640 (2004).
14. Allen, T.M. et al. J. Virol. 78, 7069-7078 (2004).
15. Betts, M.R. et al. Proc. Natl. Acad. Sci. USA 102, 4512-4517 (2005).